"Virulence Factors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Those components of an organism that determine its capacity to cause disease but are not required for its viability per se. Two classes have been characterized: TOXINS, BIOLOGICAL and surface adhesion molecules that effect the ability of the microorganism to invade and colonize a host. (From Davis et al., Microbiology, 4th ed. p486)
Descriptor ID |
D037521
|
MeSH Number(s) |
D23.946.896
|
Concept/Terms |
Virulence Factors- Virulence Factors
- Factors, Virulence
- Pathogenicity Factors
- Factors, Pathogenicity
|
Below are MeSH descriptors whose meaning is more general than "Virulence Factors".
Below are MeSH descriptors whose meaning is more specific than "Virulence Factors".
This graph shows the total number of publications written about "Virulence Factors" by people in this website by year, and whether "Virulence Factors" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2004 | 1 | 0 | 1 |
2009 | 3 | 0 | 3 |
2010 | 1 | 1 | 2 |
2011 | 2 | 1 | 3 |
2012 | 3 | 2 | 5 |
2013 | 1 | 2 | 3 |
2014 | 0 | 1 | 1 |
2015 | 1 | 0 | 1 |
2021 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Virulence Factors" by people in Profiles.
-
Andersen SE, Bulman LM, Steiert B, Faris R, Weber MM. Got mutants? How advances in chlamydial genetics have furthered the study of effector proteins. Pathog Dis. 2021 02 04; 79(2).
-
Liu-Chittenden Y, Jain M, Kumar P, Patel D, Aufforth R, Neychev V, Sadowski S, Gara SK, Joshi BH, Cottle-Delisle C, Merkel R, Yang L, Miettinen M, Puri RK, Kebebew E. Phase I trial of systemic intravenous infusion of interleukin-13-Pseudomonas exotoxin in patients with metastatic adrenocortical carcinoma. Cancer Med. 2015 Jul; 4(7):1060-8.
-
Hassan R, Sharon E, Thomas A, Zhang J, Ling A, Miettinen M, Kreitman RJ, Steinberg SM, Hollevoet K, Pastan I. Phase 1 study of the antimesothelin immunotoxin SS1P in combination with pemetrexed and cisplatin for front-line therapy of pleural mesothelioma and correlation of tumor response with serum mesothelin, megakaryocyte potentiating factor, and cancer antigen 125. Cancer. 2014 Nov 01; 120(21):3311-9.
-
Chadwick SG, Prasad A, Smith WL, Mordechai E, Adelson ME, Gygax SE. Detection of epidemic USA300 community-associated methicillin-resistant Staphylococcus aureus strains by use of a single allele-specific PCR assay targeting a novel polymorphism of Staphylococcus aureus pbp3. J Clin Microbiol. 2013 Aug; 51(8):2541-50.
-
Pogorzelska-Maziarz M, Furuya EY, Larson EL. Risk factors for methicillin-resistant Staphylococcus aureus bacteraemia differ depending on the control group chosen. Epidemiol Infect. 2013 Nov; 141(11):2376-83.
-
Yoon SW, Kayali G, Ali MA, Webster RG, Webby RJ, Ducatez MF. A single amino acid at the hemagglutinin cleavage site contributes to the pathogenicity but not the transmission of Egyptian highly pathogenic H5N1 influenza virus in chickens. J Virol. 2013 Apr; 87(8):4786-8.
-
Chadwick SG, Hart CE, Mordechai E, Adelson ME, Gygax SE. Staphylococcal Cassette Chromosome mec type and antibiotic susceptibility profiles of vaginal and nonvaginal MRSA clinical isolates. Diagn Microbiol Infect Dis. 2012 Oct; 74(2):210-2.
-
Nayak AP, Green BJ, Beezhold DH. Fungal hemolysins. Med Mycol. 2013 Jan; 51(1):1-16.
-
Thanabalasuriar A, Bergeron J, Gillingham A, Mimee M, Thomassin JL, Strynadka N, Kim J, Gruenheid S. Sec24 interaction is essential for localization and virulence-associated function of the bacterial effector protein NleA. Cell Microbiol. 2012 Aug; 14(8):1206-18.
-
Yan X, Fratamico PM, Needleman DS, Bayles DO. DNA sequence and analysis of a 90.1-kb plasmid in Shiga toxin-producing Escherichia coli (STEC) O145:NM 83-75. Plasmid. 2012 Jul; 68(1):25-32.